OneOme LLC
Pharmacogenomics software platform that analyzes genetic data to predict individual drug responses and optimize medication selection
- Sector
- Digital health
- Headquarters
- MINNEAPOLIS, MN
- Founded
- 2013
- Latest Form D
- $100K, Jun 2017
- Total capital
- $3.8M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $3.8M
- 4 Form D · last Jun 2017
- 112 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 4 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$100K
- Private capital raisedForm D · SEC · 3rd filing$530K
- Private capital raisedForm D · SEC · 2nd filing$2.1M
- Private capital raisedForm D · SEC · 1st filing$1M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Danny J. CunaginExecutive OfficerNamed in SEC Form D filings
- Harlan E. LangstraatDirectorNamed in SEC Form D filings
- Jeremy L. FrieseDirectorNamed in SEC Form D filings
- John Logan Black, IIIDirectorNamed in SEC Form D filings
- Keith L. StewartDirectorNamed in SEC Form D filings
- Mark E. SylvesterExecutive OfficerNamed in SEC Form D filings
Show all 10 people
- Matthew J. FerberDirectorNamed in SEC Form D filings
- Paul J. OwenExecutive OfficerNamed in SEC Form D filings
- Troy D. KopischkeDirectorNamed in SEC Form D filings
- Troy D. KoposchkeExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 4- PendingStratification Engine For Pharmacogenomic TestingUSPTOApplication 18064380
- PendingSystems And Methods For Genotype-derived Drug RecommendationsUSPTOApplication 15349375
- PendingStratification Engine For Pharmacogenomic TestingUSPTOApplication PCTUS2023060383
Show all 4 patent records
- Stratification Engine For Pharmacogenomic TestingJun 15, 2023 · Application 18064380Pending
- Systems And Methods For Genotype-derived Drug RecommendationsMay 17, 2018 · Application 15349375Pending
- Stratification Engine For Pharmacogenomic TestingApplication PCTUS2023060383Pending
- Stratification Engine For Pharmacogenomic TestingApplication 63288143Pending
Related companies, and why
- GeroSimilar federal contract value in Digital health · null in contracts
- OPTIMA INTEGRATED HEALTH, INC.Similar federal contract value in Digital health · null in contracts
- Rithmio, Inc.Similar federal contract value in Digital health · null in contracts
- Woebot Labs, Inc.Similar federal contract value in Digital health · null in contracts
- KINTSUGI MINDFUL WELLNESS, INC.Similar federal contract value in Digital health · null in contracts
- Gods.com,Inc.Similar federal contract value in Digital health · null in contracts
Regulatory activity · Digital health
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .